Log In
BCIQ
Print this Print this
 

ALTU-242

  Manage Alerts
Collapse Summary General Information
Company Ajinomoto Co. Inc.
DescriptionOrally administered enzyme to reduce excess levels of urate
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPreclinical
Standard IndicationHyperuricemia / gout
Indication DetailsTreat hyperuricemia/gout
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today